Medicine and Dentistry
Sorafenib
100%
Biological Marker
100%
Exosome
100%
Cancer Associated Fibroblast
100%
Hepatocellular Carcinoma
70%
Drug Resistance
40%
Tumor Microenvironment
30%
Malignant Neoplasm
30%
Long Untranslated RNA
20%
Neoplasm
20%
Cancer Growth
20%
microRNA
20%
Deoxyribonucleoprotein
10%
Cancer Stem Cell
10%
Therapy Resistance
10%
Stroma
10%
Molecularly Targeted Therapy
10%
Clinical Significance
10%
Diagnosis
10%
Cell Dedifferentiation
10%
Untranslated RNA
10%
Mesenchymal-Epithelial Transition
10%
Membrane Vesicle
10%
Tumor Cell
10%
Mediator
10%
Catheter Ablation
5%
Messenger RNA
5%
Pharmacology, Toxicology and Pharmaceutical Science
Sorafenib
100%
Malignant Neoplasm
100%
Biological Marker
100%
Liver Cell Carcinoma
63%
Drug Resistance
36%
Tumor Microenvironment
27%
Neoplasm
27%
Long Untranslated RNA
18%
Cancer Growth
18%
microRNA
18%
Untranslated RNA
9%
Therapy Resistance
9%
Deoxyribonucleoprotein
9%
Biochemistry, Genetics and Molecular Biology
Drug Resistance
57%
Sorafenib
50%
Fibroblast
50%
Sorafenib
50%
Fibroblast
50%
MicroRNA
28%
Long Non-Coding RNA
28%
Genetics
14%
Cell Dedifferentiation
14%
Cancer Stem Cell
14%
Reprogramming
14%
Mesenchymal-Epithelial Transition
14%
Membrane Vesicle
14%
Non-Coding RNA
14%
Mediator
14%
Messenger RNA
7%
Messenger RNA
7%